In addition, MERTK-activation by exogenous PROS1 supplementation increased cytotoxicity of tumor infiltrating lymphocytes against autologous melanoma cells, despite high level of MERTK expression by the autologous tumor cell line. This evidence concerns the gene MERTK and melanoma.